|

Repaglinide Clinical Trials

2 actively recruiting trials across 1 location

▲ +1 trial since June 2026

Pipeline

Phase 1: 1Phase 1/2: 1

Top Sponsors

  • Nuvalent Inc.1
  • Novartis Pharmaceuticals1

Indications

  • Cancer2
  • Advanced Malignancies1
  • Locally Advanced Solid Tumor1
  • Metastatic Solid Tumor1

Other1 trial

A Drug-drug Interaction Study to Evaluate the Effects of Pelabresib on the Pharmacokinetics of Repaglinide, Midazolam, and Combined Oral Contraceptive in Patients With Advanced Malignancies
Phase 1

Orange, California1 trial

A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

University of California Irvine Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.